HDAC9 and Friedreich ataxia: However, other HDAC inhibitors such as nicotinamide [119], sirtinol [120], splitomicin [121], LBH589 [122], and oxamflatin [123] have shown positive effects in other diseases including cancer and/or neurodegenerative disorders, and these compounds may also be considered for future FRDA therapy.